BMC Geriatrics,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Oct. 30, 2024
Sarcopenia
has
been
shown
to
be
an
important
condition
with
the
ability
predict
negative
health
outcomes,
especially
in
hospitalized
older
adults;
hence,
its
accurate
identification
role
prognosis
of
patients.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(1), P. 171 - 171
Published: Jan. 2, 2025
Background:
Nutritional
risks
in
older
adults,
such
as
malnutrition
and
sarcopenia,
are
often
underdiagnosed.
Screening
practices
frequently
rely
on
Unplanned
Weight
Loss
(UPWL),
potentially
overlooking
at-risk
individuals.
This
study
aims
to
assess
the
prevalence
of
nutritional
risk,
identified
by
UPWL
across
different
body
mass
index
categories
a
nursing
home
(NH)
population.
Methods:
Cross-sectional
data
were
collected
from
an
NH
Danish
municipality,
including
those
all
self-reliant
participants
who
consented
excluding
terminally
ill
adults.
Data
age,
sex,
height,
weight,
chronic
diseases
extracted
medical
records.
risk
was
assessed
using
two
markers:
≥1
kg
during
last
six
months
muscle
strength
via
modified
30
s
chair
stand
test
marker
sarcopenia.
An
ANOVA
Fisher’s
Exact
Test
used
differences,
followed
post
hoc
Tukey
test.
Results:
In
our
adults
(n
=
93,
mean
age
83.2
±
9.12
years,
63%
female),
17
individuals
(19%)
had
UPWL,
27
(29%)
Among
with
obesity,
twelve
(48%)
but
only
(8%)
UPWL.
contrast,
seven
(21%)
normal
weight
while
eleven
(33%)
experienced
Conclusions:
Older
NHs
at
varies
significantly
depending
whether
or
sarcopenia
markers
applied
for
categorization.
Sarcopenia
highest
obesity
group,
suggesting
need
integrating
quantity
assessments
into
community
care
identify
better.
Lipids in Health and Disease,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: Feb. 8, 2025
In
previous
studies,
several
inflammatory
biomarkers
derived
from
complete
blood
cell
counts
(CBC),
such
as
systemic
immune
inflammation
index
(SII),
neutrophil-to-lymphocyte
ratio
(NLR),
and
non‑high‑density
lipoprotein
cholesterol
to
high‑density
(NHHR)
have
been
identified
predictors
of
sarcopenia.
However,
whether
Monocyte
High-Density
Lipoprotein
Cholesterol
Ratio
(MHR)
can
predict
the
development
sarcopenia
has
not
yet
established.
The
research
first
attempts
investigate
association
between
MHR
low
muscle
mass
compare
predictive
abilities
MHR,
SII,
NLR,
NHHR
for
risk.
study
comprised
10,321
participants
aged
20
years
above
United
States.
Multiple
logistic
regression
was
performed
explore
ln-transformed
mass.
Additionally,
AUC
values
ROC
curves
were
used
assess
effectiveness
ln
other
markers
(ln
NHHR,
+
NLR).
bootstrap
estimated
95%
Cl
shown
with
AUC.
fully
adjusted
model,
NLR
positively
associated
SII:
OR
=
1.59
[1.37-1.84];
NLR:
1.35
[1.13-1.60];
NHHR:
1.49[1.27-1.75];
MHR:
1.98
[1.68-2.33];
1.61
[1.46-1.79];
1.42
[1.29-1.56];
1.58
[1.41-1.78]).
Compared
lowest
quartile
higher
quartiles
significantly
increased
odds
(P
trend
<
0.0001).
analysis,
SII
had
a
value
than
indicators
(AUC
0.608).
Ln-transformed
outperforms
in
predicting
Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
12
Published: June 6, 2024
Background
In
2022,
the
European
Society
for
Clinical
Nutrition
and
Metabolism
(ESPEN)
Association
Study
of
Obesity
(EASO)
launched
a
consensus
on
diagnostic
methods
sarcopenic
obesity
(SO).
The
study
aimed
to
identify
prevalence
agreement
SO
using
different
in
cohort
subjects
from
West
China
aged
at
least
50
years
old.
Methods
A
large
multi-ethnic
sample
4,155
participants
Health
Aging
Trend
(WCHAT)
was
analyzed.
defined
according
newly
published
ESPEN/EASO.
Furthermore,
diagnosed
as
combination
sarcopenia
obesity.
criteria
established
by
Asian
Working
Group
Sarcopenia
2019
(AWGS2019)
were
used
define
sarcopenia.
four
widely
indicators:
percent
body
fat
(PBF),
visceral
area
(VFA),
waist
circumference
(WC),
mass
index
(BMI).
Cohen’s
kappa
analyze
above
five
methods.
Results
total
part
study,
including
1,499
men
(63.76
±
8.23
years)
2,656
women
(61.61
8.20
years).
0.63–7.22%
with
diagnosis
poor-to-good
(κ:
0.06–0.67).
ESPEN/EASO
had
poorest
other
0.06–0.32).
AWGS+VFA
best
AWGS+WC
(κ
=
0.67),
AWGS+
PBF
0.32).
Conclusion
varies
considerably
between
has
highest
rate
SO,
whereas
AWGS+BMI
lowest.
relatively
good
methods,
while
poor
agreement.
AWGS+PBF
may
be
suitable
alternative
2022
Thoracic Cancer,
Journal Year:
2024,
Volume and Issue:
15(31), P. 2248 - 2259
Published: Sept. 22, 2024
Abstract
Background
Limited
information
is
available
regarding
the
impact
of
sarcopenia
on
prognosis
antiangiogenic
therapy
in
individuals
with
advanced
non‐small
cell
lung
cancer
(NSCLC).
This
study
primarily
sought
to
examine
prognostic
significance
NSCLC
undergoing
therapy.
Methods
We
retrospectively
enrolled
all
patients
who
met
inclusion
and
exclusion
criteria
from
2019
2021
at
Nantong
University
Hospital.
Patients
were
grouped
according
presence
or
absence
sarcopenia.
After
propensity
score
matching
(PSM),
progression‐free
survival
(PFS),
overall
(OS),
adverse
event
rates
compared
between
two
groups.
Factors
associated
screened
using
univariate
multivariate
analyses.
Results
A
total
267
included,
a
201
matched
baseline
after
PSM
(77
group
124
non‐sarcopenia
group).
The
had
lower
PFS
(
p
=
0.043)
OS
0.011)
than
higher
incidence
events
0.044).
Multivariate
analysis
suggested
that
an
independent
risk
factor
for
receiving
therapies
0.009).
subgroup
analyses
showed
some
differences
populations
different
characteristics.
Conclusion
comorbid
exhibit
worse
when
treated
therapy,
preventing
ameliorating
may
lead
better
outcomes
NSCLC.
Journal of Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
13(1), P. 196 - 196
Published: Dec. 29, 2023
The
accuracy
of
multi-frequency
(MF)
bioelectrical
impedance
analysis
(BIA)
to
estimate
low
muscle
mass
in
older
hospitalized
patients
remains
unclear.
This
study
aimed
describe
the
ability
MF-BIA
identify
as
proposed
by
Global
Leadership
Initiative
on
Malnutrition
(GLIM)
and
European
Working
Group
Sarcopenia
Older
People
(EWGSOP-2)
examine
association
between
mass,
dehydration,
malnutrition,
poor
appetite
patients.
In
this
prospective
exploratory
cohort
study,
was
estimated
with
against
dual-energy
X-ray
absorptiometry
(DXA)
42
adults
(≥65
years).
primary
variable
for
appendicular
skeletal
(ASM),
secondary
variables
were
index
(ASMI)
fat-free
(FFMI).
Cut-off
values
based
recommendations
GLIM
EWGSOP-2.
evaluated
DXA
absolute
mean
bias,
limits
agreement
(LOA),
(5%
10%
levels).
Agreement
sensitivity,
specificity,
negative
predictive
value
(NPV),
positive
(PPV).
visually
examined
boxplots.
overestimated
ASM
a
bias
0.63
kg
(CI:
−0.20:1.46,
LOA:
−4.61:5.87).
measures
showed
sensitivity
86%,
specificity
94%,
PPV
75%
NPV
97%.
Boxplots
indicate
that
is
lower
malnutrition.
not
observed
appetite.
We
tendency
toward
higher
dehydration.
Estimation
should
be
interpreted
caution,
but
might
Journal of Hepatocellular Carcinoma,
Journal Year:
2023,
Volume and Issue:
Volume 10, P. 1367 - 1377
Published: Aug. 1, 2023
Recent
research
has
suggested
that
sarcopenia
may
have
an
impact
on
postoperative
outcomes.
The
number
of
hepatocellular
carcinoma
(HCC)
patients
with
metabolic
dysfunction-associated
fatty
liver
disease
(MAFLD)
increased
significantly
over
time.
main
objective
this
study
was
to
investigate
the
prognosis
HCC
MAFLD
after
hepatectomy.A
multivariate
Cox
proportional
hazards
model
and
a
propensity
score
matching
(PSM)
analysis
were
conducted
ensure
baseline
characteristics
similar.
Kaplan‒Meier
survival
curves
used
compare
two
groups.This
involved
112
undergoing
hepatectomy.
Sarcopenia
indicated
as
risk
factor
for
both
recurrence-free
(RFS)
overall
(OS)
in
(p=0.002
0.022,
respectively).
After
conducting
PSM
analysis,
curve
revealed
significant
differences
RFS
OS
between
groups
(p=0.0002
p=0.0047,
All
results
showed
had
poor
hepatectomy.In
summary,
our
suggests
might
be
who
underwent
hepatectomy
through
analysis.
imperils
rates
finding
can
guide
clinical
decision-making.
For
patients,
preventing
or
treating
potentially
improve
outcomes
MAFLD.